Depression (May)

Date of Issue: 05/01/2019 | Volume: 17 | Number: 5

Issue Links:Learning Objectives | Editorial Information

This issue covers the current issues in depression treatments. It includes a lead article covering sexual side effects and SSRIs, which can be managed. The Expert Q&A discusses evidence-based dietary plans for managing depression. Plus, there’s a research update on whether depression is a risk factor for dementia.

In This Issue


Treating Sexual Side Effects

Topics: Antidepressants | Sexual Side Effects | SSRIs

Sexual side effects on SSRIs are so common that psychiatrist David Healy once argued these drugs more reliably lower libido than treat depression. Yet the problem isn’t limited to SSRIs, and it’s not unmanageable.

Read More
Expert Q&A

An Antidepressant Diet

Topics: Antidepressants | Depression | Nutrition | Registered Articles

We have a decade of observational evidence linking the quality of people’s diets to their risk for depression. Those findings were pretty consistent across countries, cultures, and age groups: A healthy diet is associated with an approximately 30% reduction in the risk for depression and a 40% improvement in cognition.

Read More
Article Links

The Antidepressant Diet: Cookbook and Patient Handouts

This page has additional materials related to the dietary suggestions made in the Expert Q&A "An Antidepressant Diet." We don’t know exactly how the diet works, but there are several possibilities.

Read More
Ask the Editor

Ask the Editor: Can Antipsychotics Enhance Cognition?

Topics: Antipsychotics | Cognition

Unlike the typical antipsychotics, atypicals improve both cognitive and psychotic symptoms of schizophrenia, so they must have procognitive effects of their own that can be harnessed in mood disorders, ADHD, and even dementia. The problem is that the data show the opposite.

Read More
Research Update

Antidepressants Don’t Raise Dementia Risk, With One Exception

Topics: Research Updates

Depression is a risk factor for dementia, but can antidepressants change that risk? Some, like paroxetine (Paxil), have anticholinergic properties that can impair cognition. This study looked at what that means for the risk of dementia.

Read More
CME Post-Test

CME Post-Test - Depression, TCPR, May 2019

Topics: CME Post-Test

The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 1 CME credit.

Read More